“We do not need more time to do this than when the patient is in the lying (supine) position and we seem to have an intra-fraction accuracy that is better than in supine, and the patient is also more comfortable.
“I think we can hypothesize to improve the patient’s experience of their treatment, but we can also imagine decreasing the side effects of radiation therapy with better repositioning and immo-bilization of the patient.”
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Stephen Towe, CEO of Leo Cancer Care, concluded: “This is a hugely important study for Leo Cancer Care but also for the field of Radiation Oncology. Up until this point there have been a number of papers published on the potential clinical benefits of upright patient positioning. This is the first paper specifically discussing the benefits of the Leo technology so it is a powerful indica-tion of our ability to live up to the hype.”
*To read the full paper - ‘Upright patient position for pelvic radiotherapy treatment’ - published by tipsRo (Technical Innovations and Patient Support in Radiation Oncology) click here
The Leo Cancer Care technology is not yet commercially available and will not treat patients until 510k or a CE mark have been achieved.
Back to HCB News
